Clinical Trial

Identifying Targets of Maladaptive Metabolic Responses in Heart Failure

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the research is to help researchers understand changes in metabolism in patients that develop heart failure.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2017-01-23; most recent amendment 2025-03-12.
Status change: Enrolling by Invitation → Active, Not Recruiting 2020-03-09
Trial Details
NCT Number NCT03032627
Lead Sponsor AdventHealth Translational Research Institute
Collaborators: Florida Hospital Cardiovascular Institute, Sanford-Burnham Medical Research Institute
Conditions Heart Failure
Enrollment 55 participants
Start Date 2017-03-20
Primary Completion 2019-06-28 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-13